Log in to your account:
Credit Suisse Upgrades Pfizer (PFE) to Outperform
January 31, 2019 4:54 AM
Credit Suisse analyst Vamil Divan upgraded Pfizer (NYSE: PFE) from Neutral to Outperform with a price target ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Analyst PT Change
Pfizer (PFE) Reports Positive CHMP Opinion for Vizimpro (dacomitinib) Positive CHMP Opinion for Vizimpro (dacomitinib) for 1st-Line Treatment of Adult Patients
February 1, 2019 9:21 AM